Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07257172

Sutureless Technique for Repositioning and Scleral Fixation of the Capsular Bag - Intraocular Lens Complex With Permanent Use of Iris Retractors

Sutureless technique for repositioning and scleral fixation of the capsular bag-intraocular lens complex with permanent use of iris retractors

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Ophthalmology Department, Military Institute of Medicine - National Research Institute

Warsaw, Masovian Voivodeship, 04-141, Poland

Location status: Recruiting

Location contact

Karolina Krix-Jachym, MD. PhD.

PRINCIPAL_INVESTIGATOR

Marek Rekas, Prof. PhD. MD.

PRINCIPAL_INVESTIGATOR

Natalia Blagun, MD

CONTACT

[email protected]

+48533179497

Natalia Blagun, MD

PRINCIPAL_INVESTIGATOR

About this study

Purpose of the study is to present results of sutureless technique for repositioning and scleral fixation of the capsular bag-intraocular lens (IOL) complex in the surgical treatment of subluxated lenses. The investigators rated the BCVA, refractive outcomes, intraocular pressure, , tilt and decentration, and also determined intra- and postoperative complications.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • only adult men and women with subluxation lens

Exclusion criteria

  • previous ocular surgery
  • Fuchs' dystrophy
  • corneal haze or scarring
  • history of corneal transplantation
  • clinically active uveitis
  • advanced glaucoma
  • macular diseases that affect visual acuity (age-related macular degeneration, diabetic maculopathy)

Treatment and study plan

Sutureless technique for repositioning and scleral fixation of the capsular bag - intraocular lens complex with permanent use of iris retractors

Procedure

The surgery was performed under retrobulbar anesthesia with 2% xylocaine and 0.5% bupivacaine. A 2.2 mm temporal clear-corneal incision and three side ports were created, followed by capsulorhexis with forceps. Due to limited vitreous prolapse, anterior vitrectomy was required. Iris retractors were inserted through the ports and positioned under the anterior capsule at the site of zonular loss. Phacoemulsification was completed with standard or reduced flow, a CTR was implanted, and a foldable one-piece IOL was placed in the bag. After removing the silicone stoppers, the retractors were lifted from the capsulotomy. A 25-gauge needle was passed 2 mm posterior to the limbus into the anterior chamber, aligned with zonular damage. The tip of one retractor was inserted into the needle and externalized; the ends were trimmed, cauterized, and the melted tip fixed subconjunctivally.

Primary outcomes

  1. BCVA

    Time frame: before and 12 months after surgery

    The change of best- corrected visual acuity

  2. RE

    Time frame: 12 months after surgery

    Postoperative total refractive error

  3. Position IOL

    Time frame: 1 month and 12 months after surgery

    Tilt and decentration IOL

Secondary outcomes

  1. Number of complications

    Time frame: from day 1 until 12 months after surgery

    Rate of complications

Study contacts

Contact information is provided by the study sponsor or research team.

Natalia Blagun, MD.

CONTACT

[email protected]

+48533179497

Sponsors and collaborators

Lead sponsor

Military Institute od Medicine National Research Institute

Other

Registry information

Important dates

Study start
2021
Primary completion
2026
Study completion
2026
First posted
Dec 2, 2025
Registry last updated
Dec 2, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.